Fluorouracil Cream 1%

Fluorouracil Cream 1% is a prescription topical medicine containing fluorouracil (5-FU), an antimetabolite that interferes with DNA and RNA synthesis in rapidly dividing cells. It is used topically for selected precancerous and superficial skin lesions, with approved uses and strengths varying by country and product.

In the United States, FLUOROPLEX® Cream is a branded 1% fluorouracil topical cream, while generic fluorouracil products and other strengths are marketed separately. The U.S. FDA labeling identifies FLUOROPLEX 1% as fluorouracil topical cream for dermatologic use.

Fluorouracil is the generic medicine name; it is not itself a brand. Brand names such as FLUOROPLEX® and Efudix®/Efudex® are market-specific branded products. Product strength, approved indications, manufacturer and brand availability differ between the USA, UK, UAE/Dubai, Australia, Singapore, Thailand, China and Russia.

Product Information

Generic Name

Fluorouracil

Active Ingredient

5-Fluorouracil (5-FU)

Strength

1% w/w

Dosage Form

Topical Cream

Route

Cutaneous / Topical

Drug Class

Antimetabolite

Pharmacological Class

Pyrimidine analogue

Therapeutic Class

Topical antineoplastic / dermatologic medicine

Common Name

5-FU Cream 1%

Prescription Status

Prescription medicine

Use

Treatment of selected abnormal, precancerous or superficial skin lesions according to the applicable product label

Reference Branded Product in the USA

FLUOROPLEX® 1% Cream

Other Fluorouracil Brands

Brand names vary by country and formulation

Active Drug

Fluorouracil

Strength

10mg fluorouracil per gram of cream

Fluorouracil 1% Cream for Actinic Keratosis

Fluorouracil 1% cream for actinic keratosis is an important commercial and informational search term.

Actinic keratoses are abnormal areas of sun-damaged skin that can contain dysplastic or precancerous keratinocytes. Fluorouracil targets rapidly dividing abnormal cells and can cause the treated area to become red, inflamed, scaly, crusted or eroded as the abnormal cells respond.

The precise strength, application schedule and treatment duration depend on the specific fluorouracil product and the treatment area.

Fluorouracil 1% Cream for Sun-Damaged Skin

Topical fluorouracil can be prescribed to treat areas of sun-damaged skin containing actinic keratoses or other eligible abnormal lesions.

An important feature of topical 5-FU treatment is that previously subtle or clinically less visible abnormal areas may become inflamed during treatment. This inflammatory response can be part of the expected pharmacological effect rather than evidence that the medicine is simply damaging healthy skin.

Fluorouracil Cream 1% Application

Fluorouracil cream should be applied only according to the instructions provided by the prescribing healthcare professional and the specific product's prescribing information.

Application schedules differ according to:

• Product formulation
• Strength
• Treatment area
• Skin condition
• Patient factors
• Country-specific labeling

For example, the U.S. FLUOROPLEX labeling describes application to affected areas and notes that treatment periods can vary by location and response.

Patients should not increase the amount or frequency of application without medical advice.

Fluorouracil 1% Cream Treatment Response

A local inflammatory response is commonly associated with topical fluorouracil treatment.

Depending on the product and treatment regimen, patients may experience:

• Redness
• Scaling
• Crusting
• Burning
• Tenderness
• Irritation
• Inflammation
• Erosion

These reactions reflect the activity of 5-FU against susceptible abnormal cells and should be monitored by the prescribing clinician.

The degree of reaction can vary considerably between patients and treatment areas.

Fluorouracil and DPD Deficiency

Fluorouracil is metabolized partly through the dihydropyrimidine dehydrogenase (DPD) pathway.

Patients with markedly reduced DPD activity can be at increased risk of fluorouracil toxicity. UK prescribing information specifically warns that systemic toxicity is more likely when the skin barrier is impaired and in individuals with DPD deficiency.

Patients should inform their healthcare professional about any known DPD deficiency or previous severe reaction to fluoropyrimidine medicines.

Fluorouracil Cream and Brivudine

An important drug-interaction consideration is brivudine and related antiviral nucleoside medicines.

UK prescribing information states that concomitant administration of fluorouracil with antiviral nucleoside drugs such as brivudine can substantially increase fluorouracil exposure and toxicity and is contraindicated.

Patients should provide their doctor and pharmacist with a complete list of current and recently used medicines before starting topical fluorouracil.

Fluorouracil 1% Cream vs 5% Cream

Both products contain the same active medicine, fluorouracil, but at different concentrations.

• Fluorouracil 1% Cream: 10mg fluorouracil per gram of cream
• Fluorouracil 5% Cream: 50mg fluorouracil per gram of cream

They should not be treated as interchangeable strengths.

The concentration, formulation, approved indications and treatment regimen can differ between products and countries. Current UK medicines information, for example, lists Fluorouracil 5% Cream and other fluorouracil-containing topical products, while the U.S. FDA label identifies FLUOROPLEX as a 1% formulation.

Fluorouracil 1% Cream vs Fluoroplex

FLUOROPLEX® is a branded U.S. product containing fluorouracil 1% topical cream.

Therefore:

Fluorouracil 1% = generic medicine/ingredient description
FLUOROPLEX® 1% = specific branded product

Do not describe generic Fluorouracil 1% Cream as FLUOROPLEX® unless the actual product being sold is the authorized FLUOROPLEX product.

The FDA label identifies FLUOROPLEX as a trademarked 1% fluorouracil cream manufactured for the U.S. market.

Fluorouracil 1% Cream vs Efudix / Efudex

Efudix and Efudex are brand names associated with fluorouracil topical products in particular markets.

They should not automatically be used as synonyms for every generic fluorouracil cream because:

• Strengths may differ
• Formulations may differ
• Manufacturers may differ
• Regulatory indications may differ
• Brand availability differs by country

For example, Australia's TGA currently lists EFUDIX fluorouracil 5% w/w cream as a registered prescription medicine, demonstrating that a branded fluorouracil product in one market may have a different strength from a U.S. 1% product.

Fluorouracil 1% Cream Availability & Ordering

Fluorouracil Cream 1% has strong commercial relevance because patients and healthcare professionals search for the active medicine, strength, topical formulation and branded equivalents.

High-intent searches include:

Fluorouracil Cream 1%, Fluorouracil 1% Cream, 5-Fluorouracil 1% Cream, 5-FU Cream 1%, Generic Fluorouracil 1% Cream, Fluorouracil 1% Topical Cream, Fluorouracil 1% for Actinic Keratosis, Fluorouracil Cream for Sun Damage, Fluoroplex 1% Generic, Fluorouracil 1% Price and Buy Fluorouracil 1% Cream.

Because regulatory status differs between jurisdictions, product descriptions should identify the actual manufacturer, strength, formulation and authorization status rather than implying that all fluorouracil 1% products are the same.

For international ecommerce, availability and prescription requirements should be checked for the USA, UK, UAE/Dubai, Australia, Singapore, Thailand, China and Russia before offering a product for sale or shipment.

How it works

Fluorouracil is a pyrimidine analogue antimetabolite.

After entering cells, fluorouracil is converted into active metabolites that interfere with nucleic-acid metabolism. One important mechanism involves inhibition of thymidylate synthase, reducing the availability of thymidine required for DNA synthesis.

Fluorouracil also affects RNA synthesis. Because rapidly dividing abnormal cells have a high requirement for DNA and RNA synthesis, they are particularly susceptible to the effects of 5-FU.

The FDA describes fluorouracil as interfering with DNA synthesis and, to a lesser extent, RNA formation.

Fluorouracil cream is used for selected precancerous and superficial skin conditions.

Depending on the exact formulation and jurisdiction, topical fluorouracil may be prescribed for conditions including:

• Actinic keratosis
• Sun-damaged skin with abnormal precancerous cells
• Selected superficial skin lesions
• Certain superficial basal-cell lesions
• Other conditions specifically listed in the approved product information

The approved indication should always be checked against the specific formulation. For example, UK fluorouracil 5% cream information includes superficial premalignant and malignant skin lesions, including keratoses, Bowen's disease and superficial basal-cell carcinoma.

Potential adverse effects of topical fluorouracil include:

• Skin irritation
• Burning or stinging
• Redness
• Inflammation
• Pain or tenderness
• Itching
• Scaling
• Crusting
• Erosion
• Allergic contact dermatitis
• Changes in pigmentation

The FDA labeling for topical fluorouracil reports pain, pruritus, burning, irritation, inflammation, allergic contact dermatitis and telangiectasia among reported adverse reactions.

Severe or unexpected reactions should be reported promptly to a healthcare professional.

Fluorouracil cream is intended for external dermatologic use.

Avoid unintended contact with:

• Eyes
• Mouth
• Nose
• Mucous membranes

Hands should be washed thoroughly after application unless the hands themselves are the prescribed treatment area.

The cream should not be applied to open cuts or significantly damaged skin unless specifically instructed by a healthcare professional. Damaged skin may increase absorption and the potential for systemic toxicity.